Abstract

AFDN/Afadin is required for establishment and maintenance of cell-cell contacts and is a unique effector of RAS GTPases. The biological consequences of RAS complex with AFDN are unknown. We used proximity-based proteomics to generate an interaction map for two isoforms of AFDN, identifying the polarity protein SCRIB/Scribble as the top hit. We reveal that the first PDZ domain of SCRIB and the AFDN FHA domain mediate a direct but non-canonical interaction between these important adhesion and polarity proteins. Further, the dual RA domains of AFDN have broad specificity for RAS and RAP GTPases, and KRAS co-localizes with AFDN and promotes AFDN-SCRIB complex formation. Knockout of AFDN or SCRIB in epithelial cells disrupts MAPK and PI3K activation kinetics and inhibits motility in a growth factor-dependent manner. These data have important implications for understanding why cells with activated RAS have reduced cell contacts and polarity defects and implicate AFDN as a genuine RAS effector.

Goudreault et al. investigate the role of Afadin downstream of RAS GTPases, substantiating this cell adhesion protein as a true RAS effector that couples its activation to cell polarity through the Scribble protein.

Details

Title
Afadin couples RAS GTPases to the polarity rheostat Scribble
Author
Goudreault, Marilyn 1 ; Gagné, Valérie 1 ; Jo, Chang Hwa 1   VIAFID ORCID Logo  ; Singh, Swati 1 ; Killoran, Ryan C. 1 ; Gingras, Anne-Claude 2   VIAFID ORCID Logo  ; Smith, Matthew J. 3   VIAFID ORCID Logo 

 Université de Montréal, Institute for Research in Immunology and Cancer, Montréal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357) 
 Mount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute, Toronto, Canada (GRID:grid.416166.2) (ISNI:0000 0004 0473 9881); University of Toronto, Department of Molecular Genetics, Toronto, Canada (GRID:grid.17063.33) (ISNI:0000 0001 2157 2938) 
 Université de Montréal, Institute for Research in Immunology and Cancer, Montréal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357); Université de Montréal, Department of Pathology and Cell Biology, Faculty of Medicine, Montréal, Canada (GRID:grid.14848.31) (ISNI:0000 0001 2292 3357) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2698989104
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.